Artiklar och insikter för Bio-Works Technologies

Bio-Works Technologies introduces WorkBeads affimAb Edge, poised to capture market share in the growing Protein A-resin industry.

Bio-Works Technologies has unveiled WorkBeads affimAb Edge, a competitive Protein A resin with strong market potential.

Bio-Works Technologies launches WorkBeads affimAb Edge, targeting the growing Protein A resin market with a competitive edge.

Bio-Works Technologies positions itself in the high-value Protein A-resin market with the launch of WorkBeads affimAb Edge.

Bio-Works Technologies största aktieägare avser att lösa in sina teckningsoptioner, vilket kan stärka bolagets kapitalbas.

Bio-Works Technologies' largest shareholders plan to exercise their warrants, potentially injecting significant capital into the company.

Bio-Works Technologies AB meddelar att flera ledande befattningshavare planerar att lösa in sina teckningsoptioner.

Bio-Works Technologies ledning meddelar att de utnyttjar sina TO 2-optioner, vilket kan stärka företagets finansiella ställning.

Bio-Works Technologies rapporterar en imponerande försäljningstillväxt på 86% under andra kvartalet 2025.

Bio-Works Technologies rapporterar en imponerande ökning av nettoomsättningen med 86% under andra kvartalet 2025.